| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 79,813 | 63,402 | ||
| Marketable securities | 11,764 | 18,145 | ||
| Accounts receivable, net | 42,444 | 40,631 | ||
| Inventories | 23,905 | 23,484 | ||
| Prepaid expenses and other current assets | 14,300 | 13,443 | ||
| Total current assets | 172,226 | 159,105 | ||
| Property and equipment, net | 467 | 472 | ||
| Operating lease right-of-use assets | 2,544 | 2,721 | ||
| Goodwill | 16,836 | 16,836 | ||
| Other non-current assets | 7,375 | 8,023 | ||
| Total assets | 199,448 | 187,157 | ||
| Current portion of operating lease liability | 740 | 723 | ||
| Accounts payable | 12,581 | 10,114 | ||
| Accrued expenses | 44,156 | 42,776 | ||
| Other current liabilities | 5,010 | 3,452 | ||
| Total current liabilities | 62,487 | 57,065 | ||
| Long-term operating lease liability | 1,810 | 2,002 | ||
| Royalty financing obligation | 34,828 | 35,318 | ||
| Other non-current liabilities | 2,098 | 2,063 | ||
| Total liabilities | 101,223 | 96,448 | ||
| Ordinary shares, nominal value of 0.01 per share 500,000 shares authorized 97,235 issued and outstanding at september30, 2025 and 96,518 issued and outstanding at december31, 2024 | 972 | 967 | ||
| Additional paid-in capital | 910,391 | 902,970 | ||
| Accumulated deficit | -789,562 | -789,582 | ||
| Accumulated other comprehensive loss | -23,576 | -23,646 | ||
| Total shareholders equity | 98,225 | 90,709 | ||
| Total liabilities and shareholders equity | 199,448 | 187,157 | ||
AVADEL PHARMACEUTICALS PLC (AVDL)
AVADEL PHARMACEUTICALS PLC (AVDL)